Who Holds AEON Biopharma, Inc. (AEON)? 22 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 22 holders, $9 million in total.
Largest holders
The 22 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Dauntless Investment Group, LLC | 12,490,154 | $9 million | +394% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 95,311 | $68,556 | +9% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 90,529 | $65,090 | +0% | 13F |
| Blue Owl Capital Holdings LP | 42,353 | $30,494 | +0% | 13F |
| Formidable Asset Management, LLC | 20,024 | $19,724 | +0% | 13F |
| StoneX Group Inc. | 18,953 | $14,942 | New | 13F |
| VANGUARD FIDUCIARY TRUST CO | 13,713 | $9,860 | -7% | 13F |
| LPL Financial LLC | 11,507 | $8,277 | +0% | 13F |
| CITIGROUP INC | 7,315 | $5,262 | +886% | 13F |
| UBS Group AG | 5,062 | $3,640 | +21% | 13F |
| BlackRock, Inc. | 2,834 | $2,038 | +0% | 13F |
| Tower Research Capital LLC (TRC) | 2,567 | $1,846 | +446% | 13F |
| Steward Partners Investment Advisory, LLC | 1,100 | $791 | +0% | 13F |
| WOLFF WIESE MAGANA LLC | 567 | $408 | +0% | 13F |
| SBI Securities Co., Ltd. | 232 | $167 | +121% | 13F |
| DUPONT CAPITAL MANAGEMENT CORP | 170 | $122 | +0% | 13F |
| MORGAN STANLEY | 150 | $108 | +0% | 13F |
| GHP Investment Advisors, Inc. | 95 | $69 | +0% | 13F |
| WELLS FARGO & COMPANY/MN | 90 | $65 | +0% | 13F |
| BARCLAYS PLC | 59 | $42 | New | 13F |
| DANSKE BANK A/S | 1 | $1 | +0% | 13F |
| Caitong International Asset Management Co., Ltd | 1 | $1 | +0% | 13F |
Questions and answers
- How many institutions hold AEON Biopharma, Inc.?
- 22 managers reported AEON Biopharma, Inc. on Form 13F for the quarter ended 30 June 2026, against 24 the quarter before.
- Who is the largest institutional holder of AEON Biopharma, Inc.?
- Dauntless Investment Group, LLC, with 12,490,154 shares worth $9 million on its 13F for Q2 2026.
- How many institutions bought or sold out of AEON Biopharma, Inc. in Q2 2026?
- 2 managers reported a new position and 4 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds AEON Biopharma, Inc., Q2 2026", https://app.tamarly.ai/holders/aeon-biopharma, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.